Table 2 Threshold targets and maximum payments
Clinical indicator | Maximum points payment | Payment stages (min-max thresholds) |
|---|---|---|
CHD 2 | 7 | 25–90% |
CHD 3 | 7 | 25–90% |
CHD 4 | 4 | 25–90% |
CHD 5 | 7 | 25–90% |
CHD 6 | 19 | 25–70% |
CHD 7 | 7 | 25–90% |
CHD 8 | 16 | 25–60% |
CHD 9 | 7 | 25–90% |
CHD 10 | 7 | 25–50% |
CHD 11 | 7 | 25–70% |
CHD 12 | 7 | 25–85% |
LVD 2 | 6 | 25–90% |
LVD 3 | 10 | 25–70% |
STROKE 2 | 2 | 25–80% |
STROKE 3 | 3 | 25–90% |
STROKE 4 | 2 | 25–70% |
STROKE 5 | 2 | 25–90% |
STROKE 6 | 5 | 25–70% |
STROKE 7 | 2 | 25–90% |
STROKE 8 | 5 | 25–60% |
STROKE 9 | 4 | 25–90% |
STROKE 10 | 2 | 25–85% |
BP2 | 10 | 25–90% |
BP3 | 10 | 25–90% |
BP4 | 20 | 25–90% |
BP5 | 56 | 25–70% |
DM 2 | 3 | 25–90% |
DM 3 | 3 | 25–90% |
DM 4 | 5 | 25–90% |
DM 5 | 3 | 25–90% |
DM 6 | 16 | 25–50% |
DM 7 | 11 | 25–85% |
DM 8 | 5 | 25–90% |
DM 9 | 3 | 25–90% |
DM 10 | 3 | 25–90% |
DM 11 | 3 | 25–90% |
DM 12 | 17 | 25–55% |
DM 13 | 3 | 25–90% |
DM 14 | 3 | 25–90% |
DM 15 | 3 | 25–70% |
DM 16 | 3 | 25–90% |
DM 17 | 6 | 25–60% |
DM 18 | 3 | 25–85% |
COPD 2 | 5 | 25–90% |
COPD 3 | 5 | 25–90% |
COPD 4 | 6 | 25–90% |
COPD 5 | 6 | 25–90% |
COPD 6 | 6 | 25–70% |
COPD 7 | 6 | 25–90% |
COPD 8 | 6 | 25–85% |
EPIL 2 | 4 | 25–90% |
EPIL 3 | 4 | 25–90% |
EPIL 4 | 6 | 25–70% |
THY2 | 6 | 25–90% |
CANCER2 | 6 | 25–90% |
MH2 | 23 | 25–90% |
MH3 | 3 | 25–90% |
MH4 | 3 | 25–90% |
MH5 | 5 | 25–70% |
ASTHMA 2 | 15 | 25–70% |
ASTHMA 3 | 6 | 25–70% |
ASTHMA 4 | 6 | 25–70% |
ASTHMA 5 | 6 | 25–70% |
ASTHMA 6 | 20 | 25–70% |
ASTHMA 7 | 12 | 25–70% |